Quris

About

Quris provides an artificial intelligence platform that predicts which drug candidates will safely work in humans.

Tel Aviv,Tel Aviv,Israel
11 - 50
https://www.quris.ai/

Highlights

Details

Last Funding Type: Seed
Last Funding Money Raised: $9M
Industries: Artificial Intelligence,Biotechnology,Health Care,Pharmaceutical,Robotics
Founded date: Jan 1, 2019
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: Quris Technologies LTD.

Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.

The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharma companies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.

Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$37M

Quris has raised a total of $37M in funding over 2 rounds. Their latest funding was raised on Dec 20, 2022 from a Seed round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 20, 2022	Seed	$9M	5	SoftBank Vision Fund	—	Detail
Jan 11, 2022	Seed	$19M	3	Welltech Ventures	—	Detail
Oct 18, 2021	Seed	$9M	3	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

2

8

Quris is funded by 8 investors. SoftBank Vision Fund and GlenRock Israel are the most recent investors.

Investor Name	Lead Investor	Funding Round
SoftBank Vision Fund	Yes	Seed
GlenRock Israel	—	Seed
iAngels	—	Seed
Richter Group	—	Seed
Welltech Ventures	—	Seed
Judith Richter	—	Seed
Kobi Richter	—	Seed
Moshe Yanai	—	Seed